Stockscreener 앱 받기
18.88
0.43%
0.08
시간 외 거래:
18.51
-0.37
-1.96%
전일 마감가:
$18.80
열려 있는:
$19.03
하루 거래량:
1.03M
Relative Volume:
0.42
시가총액:
$873.47M
수익:
$82.71M
순이익/손실:
$-102.24M
주가수익비율:
-5.1444
EPS:
-3.67
순현금흐름:
$-76.57M
1주 성능:
-2.93%
1개월 성능:
-8.88%
6개월 성능:
+85.64%
1년 성능:
+37.51%
1일 변동 폭
$18.58
$19.32
1주일 범위
$18.17
$20.20
52주 변동 폭
$3.42
$21.02
Urogen Pharma Ltd Stock (URGN) Company Profile
명칭
Urogen Pharma Ltd
전화
972 9 770 7601
주소
9 HA'TA'ASIYA ST, RA'ANANA
URGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
18.88 | 869.77M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-06-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-19 | 재개 | Ladenburg Thalmann | Buy |
| 2024-08-22 | 개시 | Guggenheim | Buy |
| 2023-02-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-27 | 개시 | Berenberg | Buy |
| 2020-04-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-13 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-09 | 개시 | National Securities | Neutral |
| 2019-05-30 | 개시 | JP Morgan | Neutral |
| 2019-05-29 | 개시 | Goldman | Neutral |
| 2019-01-29 | 개시 | H.C. Wainwright | Buy |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-04-04 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-11-15 | 재확인 | Oppenheimer | Outperform |
| 2017-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Urogen Pharma Ltd 주식(URGN)의 최신 뉴스
Can UroGen Pharma Ltd. keep up with sector leadersAnalyst Upgrade & Weekly Top Stock Performers List - خودرو بانک
Should I hold or sell UroGen Pharma Ltd. now2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - خودرو بانک
Will UroGen Pharma Ltd. stock go up in YEARJuly 2025 Chart Watch & Expert Approved Trade Ideas - خودرو بانک
Can UroGen Pharma Ltd. disrupt its industryMarket Performance Recap & Reliable Trade Execution Plans - خودرو بانک
Institutional scanner results for UroGen Pharma Ltd.Trend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
How to use Fibonacci retracement on UroGen Pharma Ltd.Quarterly Performance Summary & Precise Swing Trade Alerts - Newser
UroGen Pharma at Cantor Conference: Strategic Moves for Growth - Investing.com India
Should you avoid UroGen Pharma Ltd. stock right nowJuly 2025 Market Mood & Weekly Top Stock Performers List - خودرو بانک
UroGen Pharma at Cantor Conference: Strategic Moves for Growth By Investing.com - Investing.com Canada
How hedge fund analytics apply to UroGen Pharma Ltd. stockJuly 2025 Gainers & Free Reliable Trade Execution Plans - Newser
Published on: 2025-09-04 03:44:16 - Newser
Comparing UroGen Pharma Ltd. in custom built stock radarsTrade Risk Report & Smart Money Movement Alerts - Newser
Real time pattern detection on UroGen Pharma Ltd. stock2025 Valuation Update & Reliable Volume Spike Trade Alerts - Newser
Can momentum traders help lift UroGen Pharma Ltd.Earnings Beat & Technical Pattern Alert System - Newser
How cyclical is UroGen Pharma Ltd.’s revenue streamEarnings Growth Report & Technical Confirmation Alerts - خودرو بانک
Will UroGen Pharma Ltd. benefit from macro trendsWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
How to escape a deep drawdown in UroGen Pharma Ltd.July 2025 Trends & Target Return Focused Stock Picks - Newser
Using data filters to optimize entry into UroGen Pharma Ltd.July 2025 Short Interest & AI Optimized Trading Strategy Guides - Newser
Will earnings trigger a reversal in UroGen Pharma Ltd.2025 Market Outlook & Verified Short-Term Trading Plans - Newser
UroGen Pharma Ltd. stock prediction for this week2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
What recovery options are there for UroGen Pharma Ltd.July 2025 Summary & Reliable Volume Spike Alerts - Newser
Will breakout in UroGen Pharma Ltd. lead to full recoveryMarket Risk Report & Real-Time Buy Signal Alerts - Newser
Visual trend scoring systems applied to UroGen Pharma Ltd.Portfolio Value Report & Safe Entry Momentum Tips - Newser
What is UroGen Pharma Ltd. s 5 year growth outlookMarket Risk Report & Technical Confirmation Alerts - خودرو بانک
Will UroGen Pharma Ltd. benefit from rate cutsJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک
Heatmap analysis for UroGen Pharma Ltd. and competitorsJuly 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
Is UroGen Pharma Ltd. stock overvalued or fairly pricedQuarterly Portfolio Summary & Low Risk Entry Point Guides - خودرو بانک
Analysis Recap: Can UroGen Pharma Ltd. keep up with sector leadersJuly 2025 Retail & Safe Investment Capital Preservation Plans - خودرو بانک
Does UroGen Pharma Ltd. have declining or rising EPSQuarterly Investment Review & Verified Technical Trade Signals - خودرو بانک
Is UroGen Pharma Ltd. benefiting from innovation trendsBear Alert & Accurate Entry/Exit Alerts - خودرو بانک
What is UroGen Pharma Ltd. s P E ratio telling usJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - خودرو بانک
Historical volatility pattern of UroGen Pharma Ltd. visualizedTrade Volume Summary & Weekly Top Gainers Alerts - Newser
Analyzing drawdowns of UroGen Pharma Ltd. with statistical toolsJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Is Now a Good Time to Reenter UroGen Pharma Ltd. getLinesFromResByArray error: size == 0 - thegnnews.com
Why UroGen Pharma Ltd. stock attracts strong analyst attentionBull Run & Capital Efficient Trading Techniques - Newser
Non Muscle Invasive Bladder Cancer Pipeline Insight Report 2025 | Phase III Clinical TrialsPromising New Drug DevelopmentsResearchAndMarkets.com - FinancialContent
Technical Models Suggest UroGen Pharma Ltd. May Rebound Soon getLinesFromResByArray error: size == 0 - thegnnews.com
How to integrate UroGen Pharma Ltd. into portfolio analysis toolsWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
UroGen Pharma Ltd. stock trend outlook and recovery pathJuly 2025 Drop Watch & Real-Time Volume Analysis - Newser
UroGen Pharma Ltd. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - 더경남뉴스
Is now a turning point for UroGen Pharma Ltd.July 2025 Intraday Action & Verified Swing Trading Watchlists - Newser
Top chart patterns to watch in UroGen Pharma Ltd.Earnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Urogen Pharma Ltd (URGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Urogen Pharma Ltd 주식 (URGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Smith Jason Drew | General Counsel |
Jul 28 '25 |
Sale |
19.14 |
7,522 |
143,971 |
41,492 |
| Schoenberg Mark | Chief Medical Officer |
Jul 28 '25 |
Sale |
19.14 |
5,149 |
98,552 |
158,229 |
1.40%
자본화:
|
볼륨(24시간):